ZAYED-SUSTAINABILITY
27.1.2020 14:25:06 CET | Business Wire | Press release
Following the recent celebration of the 10 winners of the 2020 awards during Abu Dhabi Sustainability Week, the Zayed Sustainability Prize has officially announced that its submissions process for the 2021 edition is now open.
Accepting entries from today until May 21st , 2020, via its online portal, the UAE’s pioneering global award for rewarding impact, innovation, and inspiration – across five sustainability categories – saw a record-breaking number of submissions last year, with 2,373 entries received from 129 countries.
H.E. Dr. Sultan Ahmed Al Jaber, UAE Minister of State and Director General of the Zayed Sustainability Prize, said: “With a 12-year record of recognizing and rewarding excellent solutions, we are confident the Prize will continue to attract more of the world’s most dedicated innovators to submit their entries, in support of resolving the world’s most pressing sustainability challenges.
“Inspired by Sheikh Zayed’s legacy of commitment to global sustainability and humanitarianism, the Prize aligns with the emphasis our leadership has given this year to planning, preparing and finding solutions for the next 50 years.”
Now entering its 13th submissions cycle, the Prize already rewarded a total of 86 winners whose solutions or school projects have, directly and indirectly, positively transformed the lives of 335 million people, around the world.
The Prize’s US$3 million annual fund rewards winners US$600,000 in each category; the Global High Schools category is split into six world region winners, with each school able to claim up to US$100,000 to start or augment their project in their local communities. The Global High Schools category was introduced in 2012, in recognition that to empower and enhance communities of the future, the next generation of sustainability leaders need to be engaged at the school level – today.
While the scope of submissions vary, core elements of each entry lie in the innovative ways in which technology, applications and solutions are driving positive transformation of people’s lives. For the Health, Food, Energy, and Water categories, organisations should demonstrate that they are improving access to essential products or services with a long-term vision for improved living and working conditions. Many technological-based solutions often integrate with impactful long-term programmes and mechanisms like practical skills training, social entrepreneurialism, and gender empowerment.
The Zayed Sustainability Prize has a three-stage evaluation process, beginning with the due diligence conducted by an independent research and analysis consultancy. This identifies the qualified entries and results in the selection of shortlisted candidates. Evaluations are then undertaken by a Selection Committee consisting of category-specific panels of independent international experts. From this shortlist of candidates, finalists are chosen and then sent to the Prize Jury who select the winners, across all five categories.
The evaluation for the Health, Food, Energy and Water categories focus on three core criteria: Impact, Innovation, and Inspiration.
For ‘Impact’, submissions must demonstrate improved quality of human lives in a social, economic, technological, infrastructural, or environmental capacity. For ‘Innovation’, candidates should show a clear and unique value proposition, be disruptive or transformative, technically and commercially viable, and have been adopted in at least one market.
The ‘Inspiration’ criterion requires organisations to demonstrate shared values with Sheikh Zayed’s sustainability approach, have the potential to influence behaviour and actions in the wider community, and encourage others to develop complementary solutions for advancing sustainable and human development.
For the Global High Schools category, projects should be designed to be student–led, with emphasis placed on the students active involvement in planning, implementation, and monitoring processes. Projects should demonstrate innovative approaches that will also be impactful and inspirational to others. The six world regions of the Global High Schools category are: The Americas, Sub-Saharan Africa, MENA, Europe & Central Asia, South Asia, and East Asia & Pacific.
Winners of the 2021 Prize will be announced at the annual awards ceremony held during Abu Dhabi Sustainability Week, in January 2021.
For more information visit www.ZayedSustainabilityPrize.com .
About Zayed Sustainability Prize
Established by the UAE leadership, in 2008, to honour the legacy of the UAE’s founding father, the late Sheikh Zayed bin Sultan Al Nahyan, the Zayed Sustainability Prize is the UAE’s pioneering global award for recognising sustainability and humanitarian solutions, around the world.
With an annual awards ceremony, held each year during Abu Dhabi Sustainability Week, the Zayed Sustainability Prize acknowledges and rewards pioneers and innovators who are committed to developing and accelerating impactful solutions that serve disadvantaged communities and people – building a lasting legacy, today, for the future generations to come.
Zayed Sustainability Prize categories are: Health, Food, Energy, Water, Global High Schools.
Visit: www.ZayedSustainabilityPrize.com or visit our social media platforms on: Twitter , Facebook , Instagram , YouTube .
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20200127005352/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release
The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release
Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
